Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues

ABSTRACT: Current 3D tumor models for aggressive breast cancers inadequately recapitulate the native tumor microenvironment (TME), leading to poor translational potential. There is a critical need for models capable of mimicking the unique biochemical signals present in the TME. To address this gap, breast tissue and a patient derived xenograft tumor were decellularized and processed to produce breast tissue and tumor decellularized ECM (dECM). Decellularized breast tissue histology confirmed complete cellular removal and maintained extracellular matrix (ECM). Further, DNA content was significantly reduced and ECM composition (POSTN, COLI, FN1) retained. Breast dECM was incorporated (0, 5, 10, and 20 µg/mL) with triple negative breast cancer cell lines to form spheroids. Imaging and histology demonstrated that cells in low dECM (5 and 10 µg/mL) formed compact singular spheres while higher dECM concentrations (20 and 50 µg/mL) resulted in cells concentrated on the outer edge of the sphere and irregular sphere circularity. RNA-sequencing of cells seeded in dECM demonstrated gene changes mediated by both dECM inclusion in spheroids and the composition of dECM. High-density tumor dECM enhanced genes associated with metastasis while high-density breast dECM enhanced tumor suppressors and anti-metastasis genes. These findings indicate dECM as a translational model with enhanced TME inclusion.

ORGANISM(S): Homo sapiens

PROVIDER: GSE328288 | GEO | 2026/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chemoselective Characterization of New Extracellular Matrix Deposition in Bioengineered Tumor Tissues

Project description:Investigating ECM-regulated new ECM production has been challenging due to the proteomic background from the pre-existing biomaterial ECM. To address this issue the newly synthesized ECM proteins (newsECM) of two different bioengineered tumor models were analyzed: tumor tissues, built upon decellularized ECM (dECM-tumors) or as ECM-free tumor spheroids (tumoroids). newsECM proteins were labeled and enriched using a chemoselective strategy, employing a click-chemistry compatible, azido tag bearing monosaccharide probe, azido-galactosamine tetra-acetylated (Ac4GalNAz). The newsECM profiles within the two tumor models were characterized and compared by means of LC-MS/MS and subsequent follow up data analysis.

2025-08-30 | PXD061871 | Pride

Xenografted Tumor decellularization provides cell-specific in vitro 3D environment

Project description:In vitro cell culture studies are common in cancer research field, and reliable biomimetic 3D models are needed to ensure physiological relevance. In this manuscript, we hypothesized that decellularized xenograft tumors can serve as an optimal 3D substrate to generate a top-down approach for in vitro tumor modeling. Methods: Multiple tumor cell lines were xenografted and the formed solid tumors were recovered for their decellularization by several techniques and further characterization by histology and proteomics techniques. Selected decellularized tumor xenograft samples were seeded with human triple negative breast cancer (TNBC)c ells and cell behavior was compared among them and with other control 2D and 3D cell culture methods. Results: A soft treatment using Freeze-EDTA-DNAse allows proper decellularization of xenografted tumor samples. Interestingly, proteomic data show that samples decellularized from TMBC xenograft models had different extracellular matrix (ECM) composition compared to the rest of xenograft tumors tested. The in vitro re-cellularization of decellularized ECM (dECM) yields tumor-type specific cell-behavior in TNBC context. Conclusions: Data indicate that dECM derived from xenograft tumors is a feasible substrate for re-seeding purposes, thereby promoting tumor-type specific cell behavior. These data serve as a proof-of-concept for further potential generation of patient-specific in vitro research models.

2022-09-12 | PXD034597 | Pride

Bulk RNA-seq of human kidney organids in different culture conditions

Project description:To date strategies aiming to modulate cell to extracellular matrix (ECM) interactions during organoid derivation remain largely unexplored. Here, renal decellularized extracellular matrix (dECM) hydrogels have been fabricated from porcine renal cortex as new biomaterials to enrich cell-to-ECM crosstalk during the onset of kidney organoid differentiationfrom human pluripotent stem cells (hPSCs).Renal dECM derived hydrogels are used in combination with hPSC-derived renal progenitor cellsto define new approaches for 2D and 3D kidney organoid differentiation.

2025-03-03 | GSE250468 | GEO

Comparative proteomic analysis of the composition of decellularized extracellular matrix (dECM) and dECM-based inks as compared to the native tissue

Project description:Regenerative medicine and tissue engineering approaches based on the use of 3D-bioprinted decellularized extracellular matrix (dECM) present the advantage of a relatively biomolecule-rich matrix, which directs cell growth and differentiation in a tissue-specific manner. However, little is known about the composition changes that occur with standard processing of dECM-based inks. To characterize this process, six porcine tissues/tissue layers (artery, breast, dermis, epidermis, muscle and nerve) were independently decellularized via chemical, mechanical and enzymatic processes and the resulting dECMs formulated into biocompatible inks, to serve as source biomaterials for 3D printing. A comparative liquid chromatography–tandem mass spectrometry (LC–MS/MS)-based proteomic analysis was carried out for native tissue, decellularized and formulated ECMs, and the resulting complexity of the matrisome analyzed. A core matrisome was found to overlap in all decellularized tissues, as well as tissue-specific components that correlated with predicted functional (gene ontology-based) definitions. The proportion of collagens (mostly the α1 chains of collagen type I and III) increased in the final processing step (inks) as compared to the native ECM and dECM stages. Overall, a median of 55 matrisomal proteins (range 45-126) was detected in the dECM-derived inks. This complexity is far superior in terms of mimicking the composition of native tissue to non-dECM-based inks. Our results support the use of dECM-based inks and biomaterials in mimicking native tissue ECM complexity.

2025-05-15 | PXD059171 | Pride

Hybrid In Vivo Breast Cancer Model Reveals Transcriptomic Insights into Cancer Progression with Age

Project description:Aging is a key risk factor for breast cancer; however, the independent effects of the aged extracellular matrix (ECM) remain understudied. To address this, we developed a novel hybrid in vivo model that enables the independent investigation of age-related ECM influences on breast cancer development and progression. To examine the effects of genes known to be enriched in a cancerous and aged microenvironment, we first seeded normal or stable knockdown cells onto decellularized ECM (dECM) from aged murine mammary glands and implanted them into young Rag1-/- mice. We identified LOX as a principal driver of tumor progression, with knockdown reducing invasion, in vitro and in vivo, and stress-related pathways. To further isolate the independent influence of ECM aging on tumor growth, normal MCF10A cells were seeded atop young or aged matrices and implanted. Aged tumors exhibited significantly greater volume and a larger tumorigenic region when compared to young tumors, with single-cell RNA sequencing revealing enrichment of inflammatory and invasive genes. Together, these findings identify LOX as a driver of tumor progression and a potential therapeutic target and demonstrate that the aged ECM alone is sufficient to promote breast cancer progression.

2026-05-21 | GSE332708 | GEO

A Comparative Proteomic Study of Decellularized Extracellular Matrix Biomaterials Derived from Porcine Vocal Fold and Small Intestinal Submucosa Tissue Source

Project description:Decellularized extracellular matrix (dECM) is used to make regenerative biomaterials. As the ECM markups vary across organs, derived dECM products may possess different molecular and biological profiles as well. This study aims to compare the proteomic profiles of dECM biomaterials derived from small intestinal submucosa (SIS) and vocal fold (VF) tissue using mass spectrometry-based proteomics.

2023-02-01 | PXD033621 | Pride

Delineation of in vitro chondrogenesis of human synovial stem cells following preconditioning with decellularized matrix

Project description:As a tissue-specific stem cell for chondrogenesis, synovium-derived stem cells (SDSCs) are a promising cell source for cartilage repair. However, a small biopsy can only provide a limited number of cells. Cell senescence from both in vitro expansion and donor age presents a big challenge for stem cell based cartilage regeneration. Here we found that expansion on decellularized extracellular matrix (dECM) full of three-dimensional nanostructured fibers provided SDSCs with unique surface profiles, low elasticity but large volume as well as fibroblast-like shape. dECM expanded SDSCs yielded large pellets with intensive staining of type II collagen and sulfated GAGs, which was supported by both biochemical data and real-time PCR results. Our results also hint at lower levels of inflammatory genes and how they might be responsible for enhanced chondrogenic differentiation in dECM expanded SDSCs. Despite an increase of type X collagen in chondrogenically induced cells, dECM expanded cells had significantly lower potential for endochondral bone formation. Both Wnt and MAPK signals were actively involved in both expansion and chondrogenic induction of dECM expanded cells. dECM expanded human SDSCs could be a potential cell source for autologous cartilage repair Adult human synovial fibroblasts (4 donors, two male and two female, average 43 years old, all had no known joint disease) were grown for one passage on plastic flasks (P cells) or plastic flasks pre-coated with decellularized extracellular matrix (E cells). Aliquots were centrifuged and pellets cultured for 35 days in serum-free chondrogenic medium (P pellet or E pellet). There are no replicates.

2015-06-04 | E-GEOD-69531 | biostudies-arrayexpress

LC-MS/MS of Versatile Decellularized Human Lung Extracellular Matrix-Derived Hydrogels

Project description:Decellularized ECM (dECM) hydrogels derived from human lungs can provide valuable insight into patient-specific and lung pathophysiology. Herein, we present the approach and some initial results that highlight the unique characteristics of this dECM hydrogel platform and its benefits for a variety of potential future studies and applications.

2022-11-22 | MSV000090771 | MassIVE

High throughput microfluidic 3D biomimetic model enabling quantitative description of human breast tumor microenvironment

Project description:Cancer is driven by genetic aberrations in the tumor cells and fundamental changes in the tumor microenvironment (TME). These changes offer potential targets for novel therapeutics, yet lack of in vitro 3D models recapitulating this complex microenvironment impedes such progress. Here, we generated tumor-stroma spheroids reflecting the in vivo TME of early and advanced breast tumor, using a high throughput microfluidic system. The spheroids, composed of tumor cells, fibroblasts and activated immune cells, were generated and cultivated on-chip in alginate (Alg) or alginate-alginate sulfate (Alg/Alg-S) hydrogels.

2022-10-13 | PXD021509 | Pride

Umbilical cord mesenchymal stem cell spheroids loaded decellularized liver hydrogel rescues liver fibrosis by inhibiting hepatic stellate cells autophagy

Project description:Liver fibrosis (LF), driven primarily by activated hepatic stellate cells (aHSCs), progresses to life-threatening end-stage diseases such as cirrhosis, hepatocellular carcinoma. As the only effective treatment, liver transplantation remains limited by donor scarcity. While mesenchymal stem cells (MSCs) exert anti-fibrotic effects via immunomodulation, autophagy regulation, and tissue regeneration, their clinical application is hindered by poor survival, short residence time, and inefficient homing after systemic administration. Recent advances indicate that 3D MSCs spheroids enhance cell viability and paracrine function compared to monodispersed cells. Human umbilical cord MSCs (HUMSCs) are ideal due to low immunogenicity and minimal ethical concerns. Injectable decellularized extracellular matrix (dECM) hydrogels, particularly liver-derived ECM (LdECM), offer a bioactive microenvironment to support cell retention and sustained release.HUMSCs spheroids (HUMSCs sph) were engineered using AggreWell™ plates. An injectable hydrogel was fabricated from decellularized Sprague-Dawley (SD) rat liver scaffolds (LdECM). A novel therapeutic strategy for LF was developed by encapsulating HUMSCs sph within LdECM hydrogels. The structure and characteristics of HUMSCs sph/sus and LdECM were assessed. The efficacy of localized high-density HUMSCs sph delivery was evaluated in a C57BL/6 mouse model of bile duct ligation/carbon tetrachloride (BDL/CCL4)-induced LF, comparing outcomes against equivalent doses of HUMSCs suspension (HUMSCs sus). HSCs autophagy and activation were detected while co-cultured with HUMSCs sph/sus.

2025-12-31 | GSE311083 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data